Current Ratio in % of Taysha Gene Therapies, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Taysha Gene Therapies, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2025.
  • Taysha Gene Therapies, Inc. Current Ratio for the quarter ending September 30, 2025 was 855 %, a 91.5% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Taysha Gene Therapies, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 855 +409 +91.5% Sep 30, 2025
Q2 2025 716 +498 +229% Jun 30, 2025
Q1 2025 537 +372 +225% Mar 31, 2025
Q4 2024 477 +338 +243% Dec 31, 2024
Q3 2024 447 +333 +294% Sep 30, 2024
Q2 2024 217 +85.2 +64.4% Jun 30, 2024
Q1 2024 165 +15.9 +10.7% Mar 31, 2024
Q4 2023 139 -33.3 -19.3% Dec 31, 2023
Q3 2023 113 -106 -48.2% Sep 30, 2023
Q2 2023 132 -158 -54.4% Jun 30, 2023
Q1 2023 149 -241 -61.7% Mar 31, 2023
Q4 2022 172 -392 -69.5% Dec 31, 2022
Q3 2022 219 -704 -76.3% Sep 30, 2022
Q2 2022 290 -1.2K -80.5% Jun 30, 2022
Q1 2022 390 Mar 31, 2022
Q4 2021 565 Dec 31, 2021
Q3 2021 923 Sep 30, 2021
Q2 2021 1.49K Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.